Securities code: Sichuan Kelun Pharmaceutical Co.Ltd(002422) securities abbreviation: Sichuan Kelun Pharmaceutical Co.Ltd(002422) Announcement No.: 2022039 Sichuan Kelun Pharmaceutical Co.Ltd(002422)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Sichuan Kelun Pharmaceutical Co.Ltd(002422) (hereinafter referred to as "the company") held the 11th meeting of the 7th board of directors on April 7, 2022. The proposal on the remuneration of senior managers of the company in 2021 and the remuneration plan in 2022 was deliberated and adopted by 7 votes in favor, 0 votes against and 0 abstentions. Mr. Liu Sichuan, a director related to the interests of the matter, avoided voting. The details are announced as follows:
1、 Salary in 2021
The company assessed the senior managers according to the 2021 annual salary plan for senior managers deliberated and adopted at the first meeting of the seventh board of directors, and determined the salary of senior managers in 2021. The details are as follows:
Name and position amount (10000 yuan)
Liu Sichuan, director and general manager 160
Tan Hongbo, deputy general manager 100
Wei Juncai, deputy general manager 100
Feng Hao, deputy general manager and Secretary of the board of directors 100
Lai Degui, deputy general manager and chief financial officer 100
Ge Tao, deputy general manager 100
Wu Zhonghua, deputy general manager 100
Ding Nanchao, deputy general manager 100
Wang Jingyi, former director and former deputy general manager 86.67
Ge Junyou, former deputy general manager 13.46
Former deputy general manager of wanyang bath 47.52
Note: Mr. Wang Jingyi resigned from the post of deputy general manager of the company on February 5, 2021, and resigned from the post of director and member of the strategy committee of the board of directors on March 25, 2022. Mr. Ge Junyou resigned as the deputy general manager of the company on February 5, 2021 due to the needs of the company's strategic development and team building. Mr. Wan Yangyu will no longer hold any position in the company after his term of office expires on July 21, 2021. The amount listed in this table is the salary amount during his tenure as a senior manager.
2、 2022 annual salary plan
In accordance with the standards for the governance of listed companies, the articles of association and the detailed rules for the implementation of the remuneration and assessment committee of the board of directors, and in combination with the industry conditions, the actual operation of the company and the business assessment requirements, the remuneration scheme for senior managers in 2022 is proposed as follows:
(I) applicable objects of this scheme
The senior managers mentioned in this plan refer to the general manager, deputy general manager, Secretary of the board of directors and chief financial officer of the company.
(II) applicable period of this scheme
The plan will be implemented on January 1, 2022 after being approved by the board of directors. Part of the salary received in 2022 before the scheme takes effect will be considered by the company after the scheme takes effect in combination with the salary situation after 2022 to ensure that the annual salary in 2022 is implemented according to the scheme.
(III) salary principle
(1) Principle of responsibility: determine the salary standard according to the factors such as job position, work performance, contribution and the combination of rights and responsibilities;
(2) Performance principle: performance compensation is linked to the completion of individual post responsibility objectives, combined with the company's business performance, rewards and punishments, annual performance appraisal results, etc., and refers to the industry salary level;
(3) Principle of overall consideration: the salary scheme is linked to the company's business performance and the completion of business objectives, and is consistent with the company's goal of sustainable and healthy development;
(4) Competition principle: pay attention to the marketization of income, formulate a reasonable salary structure proportion, and maintain the attractiveness of the company's salary and its competitiveness in the market, which is conducive to the company's attraction of talents.
(IV) salary standard
(1) Senior managers of the company shall be comprehensively evaluated according to their specific management positions in the company, actual work performance, combined with the company's annual operating performance and other factors;
(2) The salary of the company's senior managers is divided into basic salary and performance salary. The performance salary will be assessed and paid by the company according to the actual situation of production and operation and their own performance every year;
(3) The salary includes tax, and the individual income tax payable shall be uniformly withheld and paid by the company.
3、 Independent opinions of independent directors
After careful verification, the independent directors expressed their independent opinions that the company assessed the senior managers and determined the remuneration of senior managers in 2021 in accordance with the remuneration plan for senior managers of the company approved at the first meeting of the seventh board of directors. At the same time, the company has drawn up the salary plan for senior managers in 2022, which determines the salary standard of senior managers according to the working position, work performance, contribution and other factors of senior managers, and in combination with the company's business performance, rewards and punishments and annual performance appraisal results. The plan meets the needs of the company's future development, is conducive to mobilizing the enthusiasm and creativity of the company's senior managers, improving the company's operation and management efficiency, maintaining the stability of the core management team and promoting the sustainable and healthy development of the company. The company's remuneration in 2021 and the remuneration plan in 2022 comply with the provisions of relevant laws, regulations and the articles of Association; It is conducive to the diligence of senior managers, the stable operation and long-term development of the company, and there is no damage to the interests of the company and all shareholders, especially small and medium-sized shareholders. We agree with the company's remuneration in 2021 and the remuneration plan in 2022.
4、 Documents for future reference
(I) resolutions of the 11th meeting of the 7th board of directors of the company;
(II) independent opinions of independent directors on relevant matters of the 11th meeting of the seventh board of directors.
It is hereby announced.
Sichuan Kelun Pharmaceutical Co.Ltd(002422) board of directors April 11, 2022
